Boothbay Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,819
| Closed | -$8.42M | – | 1874 |
|
|
2025
Q1 | $8.42M | Buy |
+63,819
| New | +$7.95M | 0.22% | 102 |
|
|
2024
Q2 | – | Sell |
-5,700
| Closed | -$394K | – | 1916 |
|
|
2024
Q1 | $394K | Buy |
+5,700
| New | +$392K | 0.01% | 1097 |
|
|
2021
Q4 | – | Sell |
-19,851
| Closed | -$740K | – | 2294 |
|
|
2021
Q3 | $740K | Sell |
19,851
-19,219
| -49% | -$668K | 0.02% | 898 |
|
|
2021
Q2 | $1.59M | Hold |
39,070
| – | – | 0.05% | 485 |
|
|
2021
Q1 | $1.33M | Buy |
39,070
+2,528
| +7% | +$87.7K | 0.05% | 478 |
|
|
2020
Q4 | $1.16M | Sell |
36,542
-9,505
| -21% | -$250K | 0.04% | 445 |
|
|
2020
Q3 | $1.18M | Buy |
+46,047
| New | +$1.05M | 0.07% | 380 |
|
|
2020
Q2 | – | Sell |
-61,884
| Closed | -$1.25M | – | 1128 |
|
|
2020
Q1 | $951K | Buy |
+61,884
| New | +$1.34M | 0.08% | 315 |
|
|
2018
Q4 | – | Sell |
-17,000
| Closed | -$369K | – | 939 |
|
|
2018
Q3 | $369K | Buy |
+17,000
| New | +$355K | 0.04% | 452 |
|
|
2018
Q2 | – | Sell |
-11,300
| Closed | -$238K | – | 929 |
|
|
2018
Q1 | $238K | Buy |
+11,300
| New | +$220K | 0.03% | 553 |
|
|
2017
Q1 | – | Sell |
-12,303
| Closed | -$186 | – | 976 |
|
|
2016
Q4 | $186 | Buy |
+12,303
| New | +$174K | 0.04% | 617 |
|
Other funds holding ITCI
KIM
HNB